Facebook Linkedin RSS Twitter Youtube
Home 2023

IsoPlexis system

A Functional Cell Biology Company Is Formed
Bioprocessing

A Functional Cell Biology Company Is Formed

Single-Cell Advances in Functional Immune Monitoring for Developing Immune Therapies and Uncovering Disease Pathogenesis
Cancer

Single-Cell Advances in Functional Immune Monitoring for Developing Immune Therapies and Uncovering Disease Pathogenesis

Getting in Touch with Multiomics
Insights

Getting in Touch with Multiomics

Single-Cell Functional Proteomics
OMICs

Single-Cell Functional Proteomics

IsoPlexis Wraps Functional Single-Cell Proteomics in a Bow
GEN Edge

IsoPlexis Wraps Functional Single-Cell Proteomics in a Bow

IsoPlexis Nets $111M from IPO to Expand Platform, Product Offerings, Distribution Network
News

IsoPlexis Nets $111M from IPO to Expand Platform, Product Offerings, Distribution Network

Single-Cell Proteomics Predicts Progression-Free Survival in Melanoma Study
Cancer

Single-Cell Proteomics Predicts Progression-Free Survival in Melanoma Study

Single-Cell Proteomics Connects Gaps in Traditional DNA & RNA Sequencing
OMICs

Single-Cell Proteomics Connects Gaps in Traditional DNA & RNA Sequencing

GEN Interview: Sean Mackay, CEO and Co-Founder, IsoPlexis
Sponsored

GEN Interview: Sean Mackay, CEO and Co-Founder, IsoPlexis

Highly Automated Precision Medicine is the Future of Cellular Immunotherapy
Drug Discovery

Highly Automated Precision Medicine is the Future of Cellular Immunotherapy

12Page 1 of 2
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.